Comprehensive coverage

Medicines

Elimination of lymphoma cells in mice. Courtesy of the researchers

focus on the goal

Researchers created a composition of nanoparticles that was able to destroy lymphoma cells in mice
drug development. Illustration: depositphotos.com

New insights into polymorphisms could influence drug development

  • No comments
Researchers have used a variety of methods in order to reveal the different polymorphs that can be prepared from a common crystalline material and the paths of conversion of one configuration to another depending on the temperature and the method of preparation
The illustration is courtesy of Medidata

Medidata opens access to its Patient Insights Program to research organizations

  • No comments
This is a system that allows research organizations to leverage the Patient Centricity by Design process to plan clinical trials, among other things to be able to follow the patients who participated in the clinical trials after the trial
Pharmaceutical factory. Illustration: depositphotos.com

Dassault Systèmes collaborates with Sanofi in the planning and optimization of pharmaceutical factories

  • No comments
Sanofi will build a factory in virtual space that will operate during an epidemic and produce vaccines to accelerate the development of vaccines
mRNA. Illustration: depositphotos.com

Moderna and IBM will investigate the development of mRNA-based therapies with the help of quantum computing and artificial intelligence

  • One response
As part of the collaboration, IBM will provide modern scientists with access to quantum computing systems, and they will learn how quantum computing technologies can be applied to problems that were previously intractable for classical computers.
The type of side chain affects the anchoring ability of the ring peptide to the cell membrane. Stephanie M. Linker et al. Journal of Medicinal Chemistry 2023 66 (4), 2773-2788

How drugs enter the blood

  • One response
First, the molecule anchors itself to the surface of the membrane, before it penetrates the membrane in a direction perpendicular to it. In the next step, it changes its three-dimensional structure while passing through the membrane, rotating once along the longitudinal axis before reaching the opposite side of the membrane, where it exits the membrane again
when age Photography: Elad Malka

AION Labs is establishing the startup DenovAI that will deal with the design of antibodies and drugs

  • No comments
DenovAI will combine machine learning and computational biophysics to discover antibodies with a wider scope, faster and cheaper, and to improve the probability of success of drug candidates. This is the second company established by the innovation laboratory of Teva, Pfizer, Merck, AssertaZeneca, Amazon (AWS), BioMed X and the Israel Biotech Foundation
The macrocyclic compound P6AS can trap a variety of drugs that can cause overdose, including opioids, hallucinogens and stimulants, thanks to a hydrophobic internal niche. [Courtesy: © Brockett et al., Chem 9, 1–20 April 13, 2022 Elsevier Inc]

A molecular trap capable of trapping drugs after overdoses

  • No comments
An innovative macroring material can trap a variety of drugs in overdose cases, including opioids, hallucinogens and stimulants, thanks to its hydrophobic niche
Technion researchers with Pfizer Chairman and CEO Dr. Albert Borla. From right to left: Dr. Uri Shalit, Dr. Dvir Aran, Prof. Shai Shen-Or, Dr. Albert Borla, Prof. Tomer Shlomi and Dr. R. Nega Ron-Harel Photo credit: Nitzan Zohar, Technion spokespeople

The Technion and Pfizer signed a cooperation agreement to accelerate scientific breakthroughs through artificial intelligence

  • No comments
The Technion recently launched Tech.AI, a center that brings together the Technion's biomed activity in the field of AI and makes research and application at the forefront of AI accessible to researchers from all units at the Technion
From right to left - Itai Katzir and Der Ila Lampal. Tel Aviv University spokeswoman photo

New technology will allow the isolation of many molecules in a single storage cell and their release through exposure to UV radiation

  • No comments
The researchers estimate that the development will advance the construction of systems for storing biomolecules and drugs and their efficient and controlled release when needed by external stimulation, using light
Prof. Yosef Shaul. The virus ignited his imagination

FDA approval for a third generation vaccine for viral hepatitis B

The component was developed based on the research of Prof. Yosef Shaul
A clinical trial from the patient's perspective. Illustration: depositphotos.com

Designing clinical trials with a patient-oriented approach

  • No comments
Medidata opens access to its Patient Insights Program, enabling research organizations to leverage the Patient Centricity by Design process to plan clinical trials
Illustration: depositphotos.com

The innovation laboratory AION Labs, with the support of BioMed X, publishes a first call for the discovery of therapeutic antibodies using artificial intelligence

  • No comments
AION Labs, the Israeli innovation laboratory of AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund and Amazon Web Services (AWS), is launching a first procedure to create a new venture based on the innovation model of the German BioMed X Institute * The calling voice is intended to identify talents Worlds in research for a new start-up company in the field of computational design from scratch of therapeutic antibodies
Mati Gil and Yair Benita, ALON LABS. Photography: Elad Malka

A laboratory was launched for the use of AI for drug development in collaboration with Pfizer, Teva, AstraZeneca, Merck and Amazon

  • No comments
AION Labs unites the pharma companies, technology and funds including IBF to invest in the start-up companies to integrate the developments in the field of cloud computing and artificial intelligence to improve the ability to develop medicines
clinical trial. Illustration: depositphotos.com

Medidata Adjudicate A unified solution for examining clinical endpoints

  • No comments
A uniform digital solution for all endpoints of clinical trials, integrated with the Medidata Clinical Cloud
Medicines. Image: depositphotos.com

Many find it difficult to swallow medicines because of their repulsive taste - will a new method make them friendlier to humans?

Clinical Trials. Image: depositphotos.com

Medidata will help manage the clinical studies of the pharmaceutical company Horizon

  • No comments
Horizon will access a wide range of clinical trial solutions through the Medidata Rave Clinical Cloud platform, to accelerate clinical research through a suite of applications that includes data collection and management, trial design and management
Fungal infection. Illustration: shutterstock

The European Research Council (ERC) will grant approximately 10 million euros to researchers from Tel Aviv University and the Charita University of Medicine Berlin

  • No comments
The goal of the research is to lead to the development of antifungal drugs and combined treatments that will be effective against life-threatening invasive fungal infections
fire Currently approved for the treatment of prostate cancer patients in early stages in Europe, Mexico and Israel

New light on "Toked"

Follow-up using a new imaging method, changes were discovered that lead to the eradication of the tumor in a selective manner and without damage to the adjacent tissues 
Teva and the Technion announce a collaboration to promote innovative research and development in the fields of cancer and the brain. PR photo

Teva and the Technion announce a collaboration to promote research and development in the fields of cancer and the brain

  • No comments
drug search. From Jumpstory.com

Britain and Switzerland have joined the consortium led by IBM to accelerate research to find a vaccine and a cure for the corona virus

  • One response
Introducing a "prodrug" into the body. From the scientific article. Courtesy of the Weizmann Institute

Trojan drug

  • No comments
The corona virus. Illustration: Jumpstory.com

Your computer can help scientists find a treatment for Corona

  • 4 תגובות
Bacterial resistance to antibiotics. Illustration: shutterstock

Artificial intelligence has discovered a surprising new antibiotic

  • 3 תגובות
From right to left: Prof. Itai Benhar, Almog Biton and Prof. Ariel Munitz. Courtesy of Tel Aviv University

Researchers in Tel Aviv discovered a central mechanism that causes "asthma of the skin"

  • 5 תגובות
Science website logo
SEARCH